Search
CTA30X UCAR-T
go.drugbank.com/drugs/DB24819InvestigationalCTA30X UCAR-T is a biologic drug. CTA30X UCAR-T is under investigation in clinical trial NCT05015972 (UCAR-T for CD19+ Refractory/Relapsed B Hematologic Malignancies).
E-6201
go.drugbank.com/drugs/DB11687InvestigationalE6201 has been investigated for the treatment of Chronic Plaque Psoriasis.
Tegobuvir
go.drugbank.com/drugs/DB11852InvestigationalTegobuvir has been investigated for the treatment of Hepatitis C, Chronic.
Pilsicainide
go.drugbank.com/drugs/DB12712InvestigationalPilsicainide has been investigated for the treatment of Paroxysmal Atrial Fibrillation.
Olitigaltin
go.drugbank.com/drugs/DB12895InvestigationalOlitigaltin has been investigated for the treatment of Idiopathic Pulmonary Fibrosis.
Vedroprevir
go.drugbank.com/drugs/DB12037InvestigationalVedroprevir has been investigated for the treatment of Hepatitis C, Chronic.
Tavilermide
go.drugbank.com/drugs/DB12441InvestigationalTavilermide has been investigated for the treatment of Dry Eye Syndromes.
Fosbretabulin
go.drugbank.com/drugs/DB12577InvestigationalFosbretabulin has been investigated for the treatment of Anaplastic Thyroid Cancer.
E1v1.11
go.drugbank.com/drugs/DB18363ExperimentalE1v1.11 is an antisense oligonucleotide targeting the _SMN2_ gene which is under investigation for the treatment of spinal muscular atrophy (SMA).[L48196]
Alethine
go.drugbank.com/drugs/DB05800InvestigationalIt is a low molecular weight disulfide that has been shown to exhibit in vivo antitumor activity in murine myeloma and melanoma models. … Alethine is studied in the treatment of cancer. It belongs to a family of chemicals called disulfides.